CureVac (CVAC) News Today

$2.60
+0.07 (+2.77%)
(As of 04/23/2024 ET)
SourceHeadline
finance.yahoo.com logoCureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%
finance.yahoo.com - April 23 at 2:24 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Shares Gap Up to $2.44
marketbeat.com - April 22 at 12:49 PM
markets.businessinsider.com logoCureVac (CVAC) Gets a Buy from Leerink Partners
markets.businessinsider.com - April 18 at 9:51 AM
MarketBeat logoCureVac (NASDAQ:CVAC) Hits New 52-Week Low at $2.54
americanbankingnews.com - April 18 at 4:50 AM
markets.businessinsider.com logoEQS-News: CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
markets.businessinsider.com - April 17 at 8:47 AM
seekingalpha.com logoCureVac, MD Anderson team up for cancer vaccines
seekingalpha.com - April 16 at 5:22 PM
msn.com logoCureVac, MD Anderson teams up for cancer vaccines
msn.com - April 16 at 12:21 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Sets New 12-Month Low at $2.54
marketbeat.com - April 16 at 11:02 AM
marketbeat.com logoCureVac (NASDAQ:CVAC) Stock Price Down 4.8%
marketbeat.com - April 15 at 2:50 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Trading 5.7% Higher
marketbeat.com - April 5 at 12:51 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Receives "Neutral" Rating from Guggenheim
marketbeat.com - April 5 at 10:27 AM
msn.com logoCureVac, GSK Partner Release Data On Influenza Vaccine Study
msn.com - April 4 at 5:37 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Trading Down 2.4%
marketbeat.com - April 4 at 2:25 PM
markets.businessinsider.com logoEQS-News: CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
markets.businessinsider.com - April 4 at 12:36 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Short Interest Update
marketbeat.com - April 2 at 11:35 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Trading 4.3% Higher
marketbeat.com - March 28 at 3:46 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Shares Gap Up to $2.94
marketbeat.com - March 27 at 12:22 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Shares Down 6.3%
marketbeat.com - March 26 at 4:46 PM
finance.yahoo.com logoCureVac N.V.: CureVac Provides Risk-Tolerant Investors With Pure-Play Exposure to mRNA Candidates
finance.yahoo.com - March 25 at 8:14 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Shares Gap Down to $2.94
marketbeat.com - March 20 at 11:56 AM
marketbeat.com logoCureVac (NASDAQ:CVAC) Trading Down 5.9%
marketbeat.com - March 19 at 5:38 PM
marketbeat.com logoCureVac (NASDAQ:CVAC) Hits New 1-Year Low at $3.20
marketbeat.com - March 18 at 10:57 AM
finance.yahoo.com logoCVAC Oct 2024 7.500 call
finance.yahoo.com - March 16 at 9:38 AM
marketbeat.com logoCureVac (NASDAQ:CVAC) Sets New 52-Week Low at $3.27
marketbeat.com - March 12 at 12:54 PM
seekingalpha.com logoCureVac: No Momentum In Sight
seekingalpha.com - March 8 at 10:11 AM
marketbeat.com logoCureVac (NASDAQ:CVAC) Hits New 52-Week Low at $3.40
marketbeat.com - February 5 at 11:33 AM
msn.com logoJimmy Kimmel Gives Trump A Brutal Reality Check On Just How Unpopular He Is
msn.com - February 1 at 2:57 PM
finance.yahoo.com logoHere's Why We're Watching CureVac's (NASDAQ:CVAC) Cash Burn Situation
finance.yahoo.com - February 1 at 9:57 AM
finance.yahoo.com logoDown -14.25% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)
finance.yahoo.com - January 26 at 5:22 PM
finance.yahoo.com logoDown -15.09% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)
finance.yahoo.com - January 25 at 3:04 PM
marketbeat.com logoShort Interest in CureVac (NASDAQ:CVAC) Increases By 9.9%
marketbeat.com - January 15 at 7:35 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN), CureVac (CVAC) and Immunocore Holdings (IMCR)
markets.businessinsider.com - January 6 at 1:15 AM
msn.com logoWhy Biopharmaceutical Player CureVac Shares Are Rising Today
msn.com - January 5 at 3:15 PM
markets.businessinsider.com logoCureVac Announces Positive Phase 2 Results For COVID-19 Vaccine Candidates
markets.businessinsider.com - January 5 at 10:15 AM
marketbeat.com logoCureVac (NASDAQ:CVAC) Short Interest Down 11.6% in December
marketbeat.com - January 1 at 11:40 PM
finance.yahoo.com logoThese Analysts Just Made A Huge Downgrade To Their CureVac N.V. (NASDAQ:CVAC) EPS Forecasts
finance.yahoo.com - December 22 at 6:28 AM
realmoney.thestreet.com logoCureVac price target lowered to $6.40 from $8 at BofA
realmoney.thestreet.com - December 20 at 4:33 AM
markets.businessinsider.com logoCureVac Buy Rating Affirmed Despite Patent Setback, Strong Appeal Prospects Anticipated
markets.businessinsider.com - December 20 at 4:33 AM
bizjournals.com logoGerman patent court deals CureVac a blow to Covid vaccine IP
bizjournals.com - December 19 at 5:17 PM
marketwatch.com logoCureVac stock down 43.5% in premarket trading
marketwatch.com - December 19 at 3:06 PM
markets.businessinsider.com logoEQS-News: CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE
markets.businessinsider.com - December 19 at 12:17 PM
finance.yahoo.com logoCureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE
finance.yahoo.com - December 19 at 12:17 PM
msn.com logoWhy Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
msn.com - December 19 at 12:17 PM
lse.co.uk logoCurevac Share Price (1CVAC.MI)
lse.co.uk - December 18 at 7:28 AM
msn.com logoPfizer hits 52-week low, drags COVID vaccine peers on weak guidance
msn.com - December 13 at 2:43 PM
finance.yahoo.com logoAre Investors Undervaluing CureVac N.V. (NASDAQ:CVAC) By 26%?
finance.yahoo.com - December 12 at 2:03 PM
seekingalpha.com logoCureVac: Failing To Live Up To Its Initial Hype
seekingalpha.com - November 30 at 5:15 PM
finance.yahoo.com logoCan CureVac N.V. (CVAC) Climb 191.74% to Reach the Level Wall Street Analysts Expect?
finance.yahoo.com - November 21 at 1:26 PM
theglobeandmail.com logoCureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business Update
theglobeandmail.com - November 15 at 3:16 PM
markets.businessinsider.com logoAcuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology
markets.businessinsider.com - November 15 at 3:16 PM
Get CureVac News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter.

Exposed: 10 CENT Crypto to Explode April 20th? (Ad)

Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin

Click For My #1 FREE Crypto for 2024

CVAC Media Mentions By Week

CVAC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CVAC
News Sentiment

-0.46

0.46

Average
Medical
News Sentiment

CVAC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CVAC Articles
This Week

6

2

CVAC Articles
Average Week

Get CureVac News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CVAC) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners